New drug combo tested in fight against aggressive blood cancers
NCT ID NCT04937166
Summary
This early-stage study tested a new drug called DSP107, given alongside standard cancer drugs, for patients with hard-to-treat forms of leukemia and related blood disorders. The main goals were to find a safe dose and see if the combination could help control the disease. The study was terminated early and only enrolled 25 patients who had not responded well to previous treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
The University of Texas MD Anderson Cancer Center, Department of Leukemia
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.